Author Correction: A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS-FTD

Nat Med. 2024 May;30(5):1504. doi: 10.1038/s41591-024-02966-z.

Katherine E Irwin^{1

2}, Pei Jasin¹, Kerstin E Braunstein¹, Irika R Sinha^{1

2}, Mark A Garret³, Kyra D Bowden^{1

2}, Koping Chang^{1

4}, Juan C Troncoso^{1

5}, Abhay Moghekar⁵, Esther S Oh^{1

6

7}, Denitza Raitcheva⁸, Dan Bartlett⁸, Timothy Miller⁹, James D Berry³, Bryan J Traynor^{5

10

11

12}, Jonathan P Ling¹, Philip C Wong^{13

14}

¹ Department of Pathology, Johns Hopkins Medicine, Baltimore, MD, USA.
² Department of Neuroscience, Johns Hopkins Medicine, Baltimore, MD, USA.
³ Sean M. Healey & AMG Center for ALS, Massachusetts General Hospital, Boston, MA, USA.
⁴ Department and Graduate Institute of Pathology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
⁵ Department of Neurology, Johns Hopkins Medicine, Baltimore, MD, USA.
⁶ Department of Medicine, Johns Hopkins Medicine, Baltimore, MD, USA.
⁷ Department of Psychiatry and Behavioral Sciences, Johns Hopkins Medicine, Baltimore, MD, USA.
⁸ Biogen, Cambridge, MA, USA.
⁹ Department of Neurology, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
¹⁰ Neuromuscular Diseases Research Section, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA.
¹¹ National Institute of Neurological Disorders, National Institutes of Health, Bethesda, MD, USA.
¹² RNA Therapeutics Laboratory, Therapeutics Development Branch, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, MD, USA.
¹³ Department of Pathology, Johns Hopkins Medicine, Baltimore, MD, USA. [email protected].
¹⁴ Department of Neuroscience, Johns Hopkins Medicine, Baltimore, MD, USA. [email protected].

No abstract available

Publication types